Oral atenolol versus propranolol in the treatment of infantile hemangioma: A systematic review and meta-analysis

• Main Authors: Swapnil Annasaheb Pattanshetti (Author), Vidya M Mahalmani (Author), Phulen Sarma (Author), Hardeep Kaur (Author), Md Mokkaram Ali (Author), Muneer Abas Malik (Author), Nitin James Peters (Author), Manisha Prajapat (Author), Subodh Kumar (Author), Bikash Medhi (Author), Ram Samujh (Author)
• Format: Book
• Published: Wolters Kluwer Medknow Publications, 2022-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Infantile hemangioma (IH) is the most common benign vascular tumor of infancy. Propranolol is considered first-line therapy for IH. However, it is associated with side effects. Therefore, there was a need for alternative therapy. Atenolol, a selective b1-blocker may be free from such sid...